467 related articles for article (PubMed ID: 10346939)
1. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
Yu Q; Greig NH; Holloway HW; Brossi A
J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
[TBL] [Abstract][Full Text] [Related]
3. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
Zhan ZJ; Bian HL; Wang JW; Shan WG
Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.
Shinada M; Narumi F; Osada Y; Matsumoto K; Yoshida T; Higuchi K; Kawasaki T; Tanaka H; Satoh M
Bioorg Med Chem; 2012 Aug; 20(16):4901-14. PubMed ID: 22831800
[TBL] [Abstract][Full Text] [Related]
6. Methyl analogues of the experimental Alzheimer drug phenserine: synthesis and structure/activity relationships for acetyl- and butyrylcholinesterase inhibitory action.
Yu Q; Holloway HW; Flippen-Anderson JL; Hoffman B; Brossi A; Greig NH
J Med Chem; 2001 Nov; 44(24):4062-71. PubMed ID: 11708910
[TBL] [Abstract][Full Text] [Related]
7. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
[TBL] [Abstract][Full Text] [Related]
9. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Siwicka A; Moleda Z; Wojtasiewicz K; Zawadzka A; Maurin JK; Panasiewicz M; Pacuszka T; Czarnocki Z
J Pineal Res; 2008 Aug; 45(1):40-9. PubMed ID: 18284552
[TBL] [Abstract][Full Text] [Related]
10. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
[TBL] [Abstract][Full Text] [Related]
11. 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Schott Y; Decker M; Rommelspacher H; Lehmann J
Bioorg Med Chem Lett; 2006 Nov; 16(22):5840-3. PubMed ID: 16945529
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
[TBL] [Abstract][Full Text] [Related]
13. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of new 2-benzoxazolinone derivatives as potential cholinesterase inhibitors for therapy of alzheimer's disease.
SzymaĆski P; Janik A; Zurek E; Mikiciuk-Olasik E
Pharmazie; 2011 Jun; 66(6):399-403. PubMed ID: 21699076
[TBL] [Abstract][Full Text] [Related]
20. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]